Vantage Biosciences is developing a novel, oral treatment for inflammatory conditions by targeting the root drivers of inflammation. The company focuses on transforming diabetic retinopathy care.

Vantage Biosciences

Vantage Biosciences | 236 followers on LinkedIn. Transforming diabetic eye disease with an oral treatment | Vantage Biosciences is a UK-based clinical stage biotechnology company targeting the root cause of vision loss resulting from diabetes – the neuroinflammatory insult that precedes microangiopathy and leads to degeneration of the neurovascular unit of the eye. Our mission is to enable patient access to disease modifying therapy for diabetic eye disease by developing drugs that intervene at the earliest point of disease biology.

Very excited at joining the Vantage team as ClinOps VP to forge the way ahead with respect to the treatment of diabetic retinopathy.

Charmaine O'Neill

Biotech VC at ALSA Ventures

Katie Sunnucks

Clinical Project Manager at Vantage Biosciences

Steffy George

Spotlight on Vantage's Co-founder, Graeme Martin! We're thrilled to share a recent presentation by Dr Graeme Martin (PhD) on Oral Therapies for Retina at Ophthalmology Innovation Summit. Check out the presentation here: https://lnkd.in/eh8HsRXt #Ophthalmology #Innovation #VantageBiosciences #OralTherapies #Retina #OIS

We're #hiring a new Clinical Operations Manager in London, England. Apply today or share this post with your network.

Vantage Biosciences will be presenting at the upcoming Ophthalmology Innovation Source in San Diego on December 2nd, 2023. Graeme R. Martin Ph.D. will take the stage to share some exciting news regarding clinical development of VX-01, an oral therapeutic for diabetic retinopathy. This session focused on novel oral treatments for diabetic retinopathy is set to be a highlight of the Summit. Vantage is proud to be at the forefront of significant medical advances for oral treatments for diabetic eye conditions and we are excited to share our progress with the global community. Find out more: https://lnkd.in/dhSsq4MG https://ois.net/ois-xiii/ #VantageBiosciences #OpthalmologyInnovation #DiabeticRetinopathy #ClinicalInnovation #HealthcareEvents

VANT

COM:VANTAGE-BIOSCIENCES

Vantage Biosciences